Medicare Enrolled
Dr. Payam Yashar, MD
Cardiovascular Disease · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yashar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yashar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yashar
Dr. Payam Yashar is a cardiovascular disease specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yashar performed 17,237 Medicare services across 5,234 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yashar received a total of $16,747 from 52 pharmaceutical and/or device companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yashar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in CA
$16,747 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,237
Medicare services
Top 2% in CA for cardiovascular disease
5,234
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~907 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
8,529 | $105 | $750 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,182 | $109 | $400 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,148 | $13 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
1,009 | $152 | $1,000 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
619 | $190 | $1,200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
575 | $8 | $30 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
544 | $45 | $650 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
412 | $7 | $100 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
365 | $24 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
315 | $79 | $300 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 272 | $417 | $1,500 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
259 | $150 | $1,496 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
243 | $180 | $1,500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
218 | $150 | $500 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
172 | $44 | $120 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
148 | $48 | $150 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
137 | $64 | $500 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
136 | $1,292 | $4,468 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
130 | $21 | $150 |
| New patient office visit, complex (60-74 min) | 101 | $176 | $1,000 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
99 | $70 | $280 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
98 | $22 | $120 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
71 | $52 | $750 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
61 | $244 | $500 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
56 | $32 | $250 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 55 | $234 | $625 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
53 | $100 | $350 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
49 | $28 | $325 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
32 | $144 | $250 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
28 | $37 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
23 | $13 | $50 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
21 | $241 | $4,320 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
19 | $47 | $200 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
18 | $93 | $1,000 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
15 | $50 | $200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
14 | $18 | $50 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
11 | $211 | $1,940 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.2% high complexity
6.8% medium
89.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,747
Total received (2018-2024)
Avg $2,392/year across 7 years
Top 20% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
732
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,057 (95.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$690 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,304
2023
$3,495
2022
$2,597
2021
$2,698
2020
$1,711
2019
$1,905
2018
$2,037
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$286
Novartis Pharmaceuticals Corporation
$216
Janssen Biotech, Inc.
$209
Takeda Pharmaceuticals U.S.A., Inc.
$203
Amgen Inc.
$182
AIMMUNE THERAPEUTICS, INC.
$136
Regeneron Healthcare Solutions, Inc.
$96
Janssen Pharmaceuticals, Inc
$95
Alnylam Pharmaceuticals Inc.
$94
E.R. Squibb & Sons, L.L.C.
$91
Edwards Lifesciences Corporation
$78
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$71
PFIZER INC.
$60
AstraZeneca Pharmaceuticals LP
$50
HEARTFLOW, INC.
$50
Kiniksa Pharmaceuticals International, plc
$49
Lexicon Pharmaceuticals, Inc.
$42
Impulse Dynamics (USA) Inc.
$41
Mirum Pharmaceuticals, Inc.
$37
Merck Sharp & Dohme LLC
$31
Neurelis, Inc.
$29
Madrigal Pharmaceuticals
$26
GENZYME CORPORATION
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
ABBVIE INC.
$23
Ardelyx, Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$20
Novo Nordisk Inc
$20
Top 3 companies account for 30.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,551
Boston Scientific Corporation
$2,175
Abbott Laboratories
$1,930
Janssen Pharmaceuticals, Inc
$1,349
Novartis Pharmaceuticals Corporation
$1,185
PFIZER INC.
$929
Edwards Lifesciences Corporation
$845
Boehringer Ingelheim Pharmaceuticals, Inc.
$651
AstraZeneca Pharmaceuticals LP
$579
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$499
Medtronic Vascular, Inc.
$336
E.R. Squibb & Sons, L.L.C.
$283
Alnylam Pharmaceuticals Inc.
$270
BOSTON SCIENTIFIC CORPORATION
$256
Actelion Pharmaceuticals US, Inc.
$240
Takeda Pharmaceuticals U.S.A., Inc.
$233
Lundbeck LLC
$232
Janssen Biotech, Inc.
$209
Merck Sharp & Dohme LLC
$154
ABBVIE INC.
$148
Amarin Pharma Inc.
$140
AIMMUNE THERAPEUTICS, INC.
$136
Regeneron Healthcare Solutions, Inc.
$121
Kiniksa Pharmaceuticals, Ltd.
$116
Lexicon Pharmaceuticals, Inc.
$112
Merck Sharp & Dohme Corporation
$92
Impulse Dynamics (USA) Inc.
$75
BIOTRONIK INC.
$73
Bardy Diagnostics, Inc.
$68
Medtronic, Inc.
$64
HeartFlow, Inc.
$61
Lilly USA, LLC
$51
HEARTFLOW, INC.
$50
Kowa Pharmaceuticals America, Inc.
$49
Kiniksa Pharmaceuticals International, plc
$49
Kestra Medical Technology Services, Inc.
$42
Aziyo Biologics, Inc.
$37
Mirum Pharmaceuticals, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$35
Neurelis, Inc.
$29
Madrigal Pharmaceuticals
$26
NESTLE HEALTHCARE NUTRITION INC.
$25
GENZYME CORPORATION
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Arbor Pharmaceuticals, Inc.
$24
Ardelyx, Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$20
Novo Nordisk Inc
$20
Janssen Scientific Affairs, LLC
$19
SCPHARMACEUTICALS INC.
$19
SANOFI-AVENTIS U.S. LLC
$18
IDORSIA PHARMACEUTICALS US INC
$15
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ACCOLADE SR · AMVUTTRA · AVEIR · AZURE XT DR MRI SURESCAN · Ablation Therapy Hardware · Accent Pacemaker · Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BIOMONITOR · BRILINTA · BYDUREON · BodyGuardian · CAMZYOS · CLINICAL TRIAL PRODUCT · CONFIRM RX · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · DIFICID · DUPIXENT · DYNAGEN · ECM · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENTRESTO · ENTYVIO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FUROSCIX · Fortify Assura · GALLANT · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL THERAPIES · General - Brady · General - Therapies · IBSRELA · ICDs · INGEVITY · INGEVITY MRI · INTELLANAV · INTELLATIP · ISOFLEX · Inpefa · JARDIANCE · JOT DX · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LOKELMA · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Linzess · Livalo · Livmarli · MAESTRO 4000 · MOUNJARO · MYCARELINK · Merlin Connectivity and Remote · Micra · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PAXLOVID · PRADAXA · PRALUENT · Proclaim Family of SCS IPGs · QUARTET · QUVIVIQ · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RELIANCE 4 FRONT · RESMETIROM · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · Rivacor · SAPIEN 3 Ultra RESILIA · SKYRIZI · STEGLATRO · STELARA · SYMBICORT · TENDRIL · TRADJENTA · TREMFYA · TRULICITY · UPTRAVI · VALTOCO · VERQUVO · VIGILANT · VOWST · VRAYLAR · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · XARELTO · XIFAXAN · ZENPEP · ZOOM · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
585
Per 100K population
5.9
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yashar is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yashar experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Yashar performed 8,529 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yashar receive payments from pharmaceutical companies?
Yes. Dr. Yashar received a total of $16,747 from 52 companies across 732 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yashar's costs compare to other cardiologists in Los Angeles?
Dr. Yashar's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yashar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Los Angeles
Browse cardiologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology